Inflammatory Myositis Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | CSL Behring, Argenx, PriovantTherapeutics/Roivant, Alexion Pharmaceuticals, Immunoforge Co. Ltd., Argenx, Janssen, Abcuro, Inc., Horiz

DelveInsight's "Inflammatory Myositis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Inflammatory Myositis, historical and forecasted epidemiology as well as the Inflammatory Myositis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Inflammatory Myositis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Inflammatory Myositis Market Forecast

Some of the key facts of the Inflammatory Myositis Market Report: https://www.delveinsight.com/sample-request/inflammatory-myositis-im-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• The Inflammatory Myositis market size was valued approximately USD 575 million in 2022 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In the 7MM, there were 184,204 diagnosed prevalent instances of inflammatory myositis in total in 2022; by 2032, it was projected to rise by 2.4% CAGR
• The US, with 90,064 instances, had the most diagnosed common cases of inflammatory myositis among the 7MM in 2022, followed by the EU4, the UK, and Japan (each with 68,079) and the US (with 26,060 cases)
• In EU4 and the UK in 2022, there were 68,079 diagnosed common cases of inflammatory myositis. With 21,734 affected people, Germany had the most diagnosed prevalent cases, followed by Italy (14,776) and the UK (13,590). These cases are anticipated to rise in 2022 during the study period
• Polymyositis, Dermatomyositis, and Inclusion Body Myositis accounted for 74,916, 82,534, and 26,754 cases in the 7MM, respectively, of the type-specific cases
• Key Inflammatory Myositis Companies: CSL Behring, Argenx, PriovantTherapeutics/Roivant, Alexion Pharmaceuticals, Immunoforge Co. Ltd., Argenx, Janssen, Abcuro, Inc., Horizon Therapeutic, Galapagos NV, Priovant Therapeutics/Roivant.Alexion Pharmaceuticals, Alexion Pharmaceuticals, Pfizer, Kezar Life Sciences, and others
• Key Inflammatory Myositis Therapies: Hizentra, Efgartigimod, Brepocitinib, Ultomiris, PF 1801, Efgartigimod, Nipocalimab, ABC008, Daxdilimab (HZN-7734/MEDI7734/VIB7734), Enpatoran, GLPG3667, Brepocitinib (PF-06700841), ULTOMIRIS (Ravulizumab), PF-06823859 (Dazukibart), Zetomipzomib (KZR-616), and others
• Hizentra, developed by CSLBehring, Efgartigimod, manufactured by Argenx, and Brepocitinib, produced by Priovant Therapeutics/Roivant, among others, are some of the potential medicines anticipated to be launched within the projected period. These prospective medicines show promise in the treatment of inflammatory myositis, and their introduction is anticipated to have an effect on the range of therapeutic options throughout the anticipated time frame.
• The Inflammatory Myositis epidemiology based on gender analyzed that females are more susceptible to suffer from Inflammatory myositis when compared to the male population, in the 7MM
• The Inflammatory Myositis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Inflammatory Myositis pipeline products will significantly revolutionize the Inflammatory Myositis market dynamics.

Inflammatory Myositis Overview
Myositis, commonly referred to as inflammatory myositis, is a class of uncommon autoimmune diseases marked by muscle inflammation. Inflammatory myositis comes in a variety of forms, such as necrotizing autoimmune myopathy, inclusion body myositis, polymyositis, and dermatomyositis.

Get a Free sample for the Inflammatory Myositis Market Report
https://www.delveinsight.com/report-store/inflammatory-myositis-im-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Inflammatory Myositis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Inflammatory Myositis Epidemiology Segmentation:
The Inflammatory Myositis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Inflammatory Myositis
• Prevalent Cases of Inflammatory Myositis by severity
• Gender-specific Prevalence of Inflammatory Myositis
• Diagnosed Cases of Episodic and Chronic Inflammatory Myositis

Download the report to understand which factors are driving Inflammatory Myositis epidemiology trends @ Inflammatory Myositis Epidemiology Forecast
https://www.delveinsight.com/sample-request/inflammatory-myositis-im-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Inflammatory Myositis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Inflammatory Myositis market or expected to get launched during the study period. The analysis covers Inflammatory Myositis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Inflammatory Myositis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Inflammatory Myositis Therapies and Key Companies
• Hizentra: CSL Behring
• Efgartigimod: Argenx
• Brepocitinib: PriovantTherapeutics/Roivant
• Ultomiris: Alexion Pharmaceuticals
• PF 1801: Immunoforge Co. Ltd.
• Efgartigimod: Argenx
• Nipocalimab: Janssen
• ABC008: Abcuro, Inc.
• Daxdilimab (HZN-7734/MEDI7734/VIB7734): Horizon Therapeutics
• Enpatoran (M5049): Merck KGaA
• GLPG3667: Galapagos NV
• Brepocitinib (PF-06700841): Priovant Therapeutics/Roivant
• ULTOMIRIS (Ravulizumab): Alexion Pharmaceuticals
• PF-06823859 (Dazukibart): Pfizer
• Zetomipzomib (KZR-616): Kezar Life Sciences

Discover more about therapies set to grab major Inflammatory Myositis market share @ Inflammatory Myositis Treatment Market

Inflammatory Myositis Market Strengths
• The therapeutic landscape is prolific in determining the efficacy, safety, and tolerability of novel drugs in patients with IM and its various types.

Inflammatory Myositis Market Opportunities
• The rising data on overall IM prevalence and its subtypes is expected to add significantly to the patient pool

Scope of the Inflammatory Myositis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Inflammatory Myositis Companies: CSL Behring, Argenx, PriovantTherapeutics/Roivant, Alexion Pharmaceuticals, Immunoforge Co. Ltd., Argenx, Janssen, Abcuro, Inc., Horizon Therapeutic, Galapagos NV, Priovant Therapeutics/Roivant.Alexion Pharmaceuticals, Alexion Pharmaceuticals, Pfizer, Kezar Life Sciences, and others
• Key Inflammatory Myositis Therapies: Hizentra, Efgartigimod, Brepocitinib, Ultomiris, PF 1801, Efgartigimod, Nipocalimab, ABC008, Daxdilimab (HZN-7734/MEDI7734/VIB7734), Enpatoran, GLPG3667, Brepocitinib (PF-06700841), ULTOMIRIS (Ravulizumab), PF-06823859 (Dazukibart), Zetomipzomib (KZR-616), and others
• Inflammatory Myositis Therapeutic Assessment: Inflammatory Myositis current marketed and Inflammatory Myositis emerging therapies
• Inflammatory Myositis Market Dynamics: Inflammatory Myositis market drivers and Inflammatory Myositis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Inflammatory Myositis Unmet Needs, KOL's views, Analyst's views, Inflammatory Myositis Market Access and Reimbursement

To know more about Inflammatory Myositis companies working in the treatment market, visit @ Inflammatory Myositis Clinical Trials and Therapeutic Assessment

Table of Contents
1. Inflammatory Myositis Market Report Introduction
2. Executive Summary for Inflammatory Myositis
3. SWOT analysis of Inflammatory Myositis
4. Inflammatory Myositis Patient Share (%) Overview at a Glance
5. Inflammatory Myositis Market Overview at a Glance
6. Inflammatory Myositis Disease Background and Overview
7. Inflammatory Myositis Epidemiology and Patient Population
8. Country-Specific Patient Population of Inflammatory Myositis
9. Inflammatory Myositis Current Treatment and Medical Practices
10. Inflammatory Myositis Unmet Needs
11. Inflammatory Myositis Emerging Therapies
12. Inflammatory Myositis Market Outlook
13. Country-Wise Inflammatory Myositis Market Analysis (2019-2032)
14. Inflammatory Myositis Market Access and Reimbursement of Therapies
15. Inflammatory Myositis Market Drivers
16. Inflammatory Myositis Market Barriers
17. Inflammatory Myositis Appendix
18. Inflammatory Myositis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Latest Reports by DelveInsight
Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.